Ogari Pacheco
13Patents
2h-index
30Co-inventors
50Inventor score
Filing activity: Oct 8, 2002 → May 22, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7816409B2 | Stable pharmaceutical composition of fluoroether compound for anesthetic use method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound | Human Necessities | 2 | Active |
| US7763653B2 | Ternary and quaternary eutectic mixtures of local anesthetics substances | Human Necessities | 2 | Active |
| US7632853B2 | Soluble, stable and concentrated pharmaceutical composition compromising ritonavir and process for preparing thereof | Human Necessities | 1 | Expired |
| US8642258B2 | Immunogenical complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica | Human Necessities | 1 | Active |
| US7495105B2 | Non-racemic mixtures of (S) and (R) enantiomers of N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; related processes and pharmaceutical compositions | Human Necessities | 0 | Expired |
| US8044247B2 | Process for the preparation of fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl) ethyl ether | Chemistry; Metallurgy | 0 | Active |
| US10597632B2 | Animal product-free culture medium for bacteria of the genus Clostridium and a process for producing supernatant comprising one or more collagenolytic and gelatinolytic proteases | Chemistry; Metallurgy | 0 | Active |
| US10865209B2 | Process for preparing temozolomide and an intermediary | Chemistry; Metallurgy | 0 | Active |
| US8541395B2 | Use of telocinobufagin as an analgesic in the treatment of acute and chronic pains | Human Necessities | 0 | Active |
| US8039678B2 | Process for the preparation of chloromethyl 2,2,2-trifluoro-1-(trifluoromethyl) ethyl ether | Chemistry; Metallurgy | 0 | Active |
| US11591243B2 | Industrial process and system for the inactivation of liquid waste | Chemistry; Metallurgy | 0 | Active |
| US10081660B2 | Polynucleotide, polypeptide with immunosuppressive activity, expression cassette, expression vector, host cell, pharmaceutical composition, methods for producing a polypeptide with immunosuppressive activity and for preventing or treating conditions that require immunosuppression, and use of a polypeptide | Human Necessities | 0 | Active |
| US9725692B2 | Animal product-free culture medium and a process for producing a supernatant of clostridium comprising one or more collagenolytic and gelatinolytic proteases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.